And if youve been using compounded tirzepatide or believe you may need it for customized dosing or ingredient concerns, you may still qualify but youll need to work with your provider to determine whats possible under the new rules
The tirzepatide before and after results and the detailed before and after tirzepatide weight loss results provide visual and numerical context for what standard dosing achieves
It targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, providing a more comprehensive approach to controlling blood sugar and body weight
There is no clinical data supporting concurrent use of two incretin-based medications targeting overlapping receptor pathways
The dose can be increased every 4 weeks to 5mg, 7.5mg, 10mg, or 15mg
They dont go through clinical trials, and theyre not evaluated by the FDA for safety or efficacy